Get the app!
Back to Trades

WILSON TROY EDWARD

DirectorCIK 0001589597

Largest Purchase

$410.1K

Kura Oncology, Inc. (KURA)

Sep 9

Profile

Filings
10
Buy transactions
3
Sell transactions
10
Companies
4
Active
2025–2026

WILSON TROY EDWARD, Director, has filed 10 reports across 4 companies, totaling $9.6M in disclosed volume. Sales ($6.2M) outpace purchases ($713.3K). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.

Trading History

10 loaded
Jun 15PBYI
PUMA BIOTECHNOLOGY, INC.
WILSON TROY EDWARDDirectorSell$77.7K
Mar 25KURA
Kura Oncology, Inc.
WILSON TROY EDWARDInsiderOther$0
Mar 2RNA
Atrium Therapeutics, Inc.
WILSON TROY EDWARDInsiderOther$0
Feb 27RNAM
Avidity Biosciences, Inc.
WILSON TROY EDWARDInsiderOther$0
Feb 26RNA
Atrium Therapeutics, Inc.
WILSON TROY EDWARDInsiderOther$0
Sep 29KURA
Kura Oncology, Inc.
WILSON TROY EDWARDInsiderSell$327.4K
Sep 9RNA
Avidity Biosciences, Inc.
WILSON TROY EDWARDDirectorSell$1.5M
Sep 9KURA
Kura Oncology, Inc.
WILSON TROY EDWARDInsiderBuy$410.1K
Aug 14KURA
Kura Oncology, Inc.
WILSON TROY EDWARDInsiderBuy$303.2K
Aug 8RNA
Avidity Biosciences, Inc.
WILSON TROY EDWARDDirectorSell$4.3M

10 filings